Global Trial in APG2575 for Patients With CLL/SLL
Clinical trial NCT06104566 · RECRUITING
Trial details
- NCT number
- NCT06104566
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2026-12-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.